SOPHiA GENETICS SA

Health technology company

SOPH Nasdaq ISIN CH1125843347 SEC CIK 1840706
Follow SOPHiA GENETICS Weekly email: filings, results

Financials

Reported figures only · latest: Q4 2025 USD · IFRS
EPS, diluted -
Revenue by quarter
$15.8M
$18.3M
Q2 24 Q2 25

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, IFRS
Revenue and net income8 fiscal years
  • Revenue
  • Net income
−$100M−$50M$0$50M$100MFY18FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearRevenueNet income
FY25$77.3M−$79M
FY24$65.2M−$62.5M
FY23$62.4M−$79M
FY22$47.6M−$87.4M
FY21$40.5M−$73.7M
FY20$28.4M−$39.3M
FY19$25.4M−$33.8M
FY18--
MarginsShare of revenue
  • Gross margin
  • Operating margin
  • Net margin
−200%−100%0%100%FY18FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearGross marginOperating marginNet margin
FY2567.4%−91.8%−102.2%
FY2467.4%−102.1%−95.9%
FY2368.8%−120%−126.6%
FY2265.7%−184.7%−183.9%
FY2162.4%−176.7%−182.1%
FY2062.3%−131.6%−138.5%
FY1970.3%-−133.2%
FY18---
Free cash flowOperating cash flow minus capital expenditure
−$80M−$60M−$40M−$20M$0FY18FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearFree cash flow
FY25−$36.5M
FY24−$44.8M
FY23−$54.7M
FY22−$74.2M
FY21−$60.6M
FY20−$32.2M
FY19−$33M
FY18-
Net margin vs the sectorMedian of Technology companies filing with the SEC
  • SOPHiA GENETICS
  • Technology median
−200%−150%−100%−50%0%50%FY18FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearSOPHiA GENETICSTechnology median
FY25−102.2%−2.3%
FY24−95.9%−5%
FY23−126.6%−6.7%
FY22−183.9%−4.4%
FY21−182.1%−1.7%
FY20−138.5%−3%
FY19−133.2%0%
FY18-0.8%